Financial

Business-focused neobank Qonto raised $552m from investors including Tencent at a $552m valuation while SK provided $350m for Center for CDMO Breakthrough Medicines.

Raw materials provider Vital Thin Film secured $188m in a round co-led by BYD while drug developers CinCor and Vigil raised a total of $292m in their initial public offerings.

2021 registered record figures in the realm of corporate venturing.

Harel contributed to drug discovery technology developer Eikon Therapeutics' $518m series B round while a host of corporates are set to exit data management software provider Trifacta in a $400m acquisition.

Nexon has invested $400m in film and television studio Agbo while responsible credit card provider Petal raised $140m in an Encore Bank and Cuna Mutual-backed round.

Coinbase Ventures has returned to back the IRA-targeted alternatives investing scheme operator, as the unit diversifies its blockchain and crypto-themed portfolio.

The digital transformation that has disrupted and reshaped the industrial sector in recent years, known as the fourth industrial revolution or industry 4.0, has now reached a new chapter with the development of what has been dubbed as industry 5.0.

Data software provider Weka raised $73m in a round led by Hitachi Ventures while Advance Publications exited social impact technology developer EverFi in a $750m acquisition.

Veon and Prosus helped B2B product marketplace ShopUp push its series B funding to $109m while Sunshine Insurance backed rounds for ImmuneOnco and Xuanzhu Biopharmaceutical.

Tencent has dodged most of China's regulatory crackdown and built an impressive fintech portfolio globally.

In the second part of our look at the year's corporate venturing trends, we analyse fintech and enterprise bull markets along with some emerging regions.